| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634589A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 03/15/2006 | EP1634499A1 Aqueous compositions for disinfection and/or sterilization |
| 03/15/2006 | EP1633783A2 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing |
| 03/15/2006 | EP1633713A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3 |
| 03/15/2006 | EP1633385A1 Compositions and methods for treatment of rosacea |
| 03/15/2006 | EP1633377A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/15/2006 | EP1633309A2 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1401435B1 Topical application of thiazolyl amides |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1283713B1 Combined cartilage and plant extract compositions |
| 03/15/2006 | EP1263426B1 Preparations for the non-traumatic excision of a nail |
| 03/15/2006 | EP1115375B1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | CN1747962A Compound, process for producing the same and use thereof |
| 03/15/2006 | CN1747746A Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 03/15/2006 | CN1747743A Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 03/15/2006 | CN1747731A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 03/15/2006 | CN1747711A Melanogenesis inhibitor and skin preparation containing the same |
| 03/15/2006 | CN1745825A Salve for treating burn and scald |
| 03/15/2006 | CN1745822A Chinese medicinal composition for treating psoriasis, its preparation and quality control |
| 03/15/2006 | CN1745816A Mixture for eliminating spots |
| 03/15/2006 | CN1745813A Activating element for preventing baldness |
| 03/15/2006 | CN1745806A Medicine for treating burn and scald and its preparation thereof |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245220C New dressing material for promoting quick repair of surface of dermal wound |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245181C Chinese medicine for treating psoriasis and its preparing process |
| 03/15/2006 | CN1245176C Externally applied medicine for treating skin ulcer |
| 03/15/2006 | CN1245082C Skin disinfectant and its preparation method |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012096 Comprising a weak organic acid such as acetic acid, vinegar, and/or citric acid dispersed within a carrier, at acidic pH, for treating burns; provides local analgesia |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012083 For prophylaxis and therapy of pruritus |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006024955A1 Azabicyclic amine histamine-3 receptor antagonists |
| 03/09/2006 | WO2006024770A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | WO2006008470A3 Treatment of tumours |
| 03/09/2006 | WO2005058314A3 Methods for reducing the effects of stress on skin condition |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060052627 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052451 Method |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 03/09/2006 | US20060052413 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052403 Novel adenine compound and use thereof |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052393 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 03/09/2006 | US20060052381 Solubilized topoisomerase poisons |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052318 Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060051867 Cell growth |
| 03/09/2006 | US20060051439 comprises acerola seed extract containing quercitrin |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051425 Method of microencapsulation |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | DE4116123B4 Mittel zur Behandlung von Hauterkrankungen Agents for the treatment of skin diseases |
| 03/09/2006 | DE202005014920U1 Pharmaceutical/dermatological/cosmetic preparation, useful for cleaning, caring and/or improving skin and hair, comprises aqueous phase or water, where a part of aqueous phase or water is replaced by a freshly prepared plant extract |
| 03/09/2006 | DE102004040630A1 Kombinationstherapie mit Procain Combination therapy with procaine |
| 03/09/2006 | CA2578016A1 Azabicyclic histamine-3 receptor antagonists |
| 03/09/2006 | CA2576827A1 Vegf inhibition |
| 03/09/2006 | CA2576781A1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction |
| 03/08/2006 | EP1632239A1 Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use |
| 03/08/2006 | EP1632231A2 Skin penetration enhancing components |
| 03/08/2006 | EP1631580A2 Methods for the preparation of dhea derivatives |
| 03/08/2006 | EP1631559A2 Il-8 receptor antagonists |
| 03/08/2006 | EP1631558A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| 03/08/2006 | EP1631295A2 Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer |
| 03/08/2006 | EP1631293A2 Compounds, formulations, and methods for treating or preventing rosacea |
| 03/08/2006 | EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |